US coverage of early PATHFINDER 2 results: when the test flagged a signal, cancer was found most of the time, with very few false alarms.
Fox News reported on early results from PATHFINDER 2, a large US study of the Galleri test in around 23,000 people. It highlighted that when the test flagged a cancer signal, a cancer was confirmed in the majority of cases, while false alarms were rare. Coverage like this shows multi-cancer blood testing entering mainstream health conversations.
Source: Fox News
